Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies.
Takahashi M, Ai T, Sinozuka K, Baba Y, Igawa G, Nojiri S, Yamamoto T, Yuri M, Takei S, Saito K, Horiuchi Y, Kanno T, Tobiume M, Khasawneh A, Paran FJ, Hiki M, Wakita M, Miida T, Suzuki T, Okuzawa A, Takahashi K, Naito T, Tabe Y. Takahashi M, et al. Among authors: paran fj. Sci Rep. 2022 Sep 1;12(1):14909. doi: 10.1038/s41598-022-19073-z. Sci Rep. 2022. PMID: 36050347 Free PMC article.
Th1 cytokine endotype discriminates and predicts severe complications in COVID-19.
Hasegawa T, Hato T, Okayama T, Ikeo K, Miyamoto Y, Iwanaga N, Suzuki K, Yoshida M, Yamashita K, Yamashita S, Tamada E, Khasawneh A, Paran FJ, Oyama R, Naito T, Noda K, Tabe Y. Hasegawa T, et al. Among authors: paran fj. Eur Cytokine Netw. 2022 Jun 1;33(2):25-36. doi: 10.1684/ecn.2022.0477. Eur Cytokine Netw. 2022. PMID: 36266985 Free PMC article.
Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment.
Takahashi M, Saito K, Ai T, Nojiri S, Khasawneh A, Paran FJ, Horiuchi Y, Takei S, Yamamoto T, Wakita M, Hiki M, Miida T, Naito T, Takahashi K, Tabe Y. Takahashi M, et al. Among authors: paran fj. PLoS One. 2023 Jan 24;18(1):e0279779. doi: 10.1371/journal.pone.0279779. eCollection 2023. PLoS One. 2023. PMID: 36693058 Free PMC article.
Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination.
Takahashi T, Ai T, Saito K, Nojiri S, Takahashi M, Igawa G, Yamamoto T, Khasawneh A, Paran FJ, Takei S, Horiuchi Y, Kanno T, Tobiume M, Hiki M, Wakita M, Miida T, Okuzawa A, Suzuki T, Takahashi K, Naito T, Tabe Y. Takahashi T, et al. Among authors: paran fj. PLoS One. 2023 Sep 19;18(9):e0291670. doi: 10.1371/journal.pone.0291670. eCollection 2023. PLoS One. 2023. PMID: 37725623 Free PMC article.
BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis.
Paran FJ, Oyama R, Khasawneh A, Ai T, Ismanto HS, Sherif AA, Saputri DS, Ono C, Saita M, Takei S, Horiuchi Y, Yagi K, Matsuura Y, Okazaki Y, Takahashi K, Standley DM, Tabe Y, Naito T. Paran FJ, et al. Front Immunol. 2024 Oct 28;15:1405013. doi: 10.3389/fimmu.2024.1405013. eCollection 2024. Front Immunol. 2024. PMID: 39530088 Free PMC article.
Carvedilol suppresses ryanodine receptor-dependent Ca2+ bursts in human neurons bearing PSEN1 variants found in early onset Alzheimer's disease.
Hori A, Inaba H, Hato T, Tanaka K, Sato S, Okamoto M, Horiuchi Y, Paran FJ, Tabe Y, Mori S, Rosales C, Akamatsu W, Murayama T, Kurebayashi N, Sakurai T, Ai T, Miida T. Hori A, et al. Among authors: paran fj. PLoS One. 2024 Aug 22;19(8):e0291887. doi: 10.1371/journal.pone.0291887. eCollection 2024. PLoS One. 2024. PMID: 39173065 Free PMC article.